Robert Azelby
Board Member
Tango Therapeutics, Inc. (TNGX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert Azelby
Robert Azelby is recorded as Board Member at Tango Therapeutics, Inc. (TNGX). Tango Therapeutics, Inc. reported in an 8-K filed June 23, 2026 that Robert Azelby was appointed director of the Company, effective June 19, 2026.
“Effective June 19, 2026, the Board appointed Robert Azelby as a director of the Company to fill the newly created vacancy on the Board resulting from the increase to the board size.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-19–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tango Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Malte Peters CEO, Board Member
- Malte Peters, M.D. CEO
- Barbara Weber, M.D. Chairman
- Matthew Gall CFO, Board Member
- Jessica Newcomb Chief Accounting Officer
- Adam Crystal Board Member
- Daniella Beckman Board Member
- James B. Avery Board Member
- John Ketchum Board Member
- Lesley Ann Calhoun Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.